Life Sciences, deals, funding
$3M for IntelligentMDx
Wade Roush 6/29/09
IntelligentMDx, a Cambridge, MA, startup developing DNA- and RNA-based tests for a range of human diseases, announced last week that it has raised an additional $3 million from a group of unnamed, non-venture investors. The new funding brings the startup’s total capital pot to $26.5 million.
Wade Roush is Xconomy's chief correspondent. You can e-mail him at wroush@xconomy.com, call him at (617) 252-7323, or follow him on Twitter at http://twitter.com/wroush.
